GLS1 dependency in MYC over-expressing multiple myeloma: New target for therapy? - ecancer
Équipe : Facteurs de Persistance des cellules leucémiques - Canther
Response to pneumococcal vaccination in multiple myeloma.,Cancer Medicine - X-MOL
Lenalidomide | Page 4 of 38 | VJHemOnc
Sequencing multiple myeloma using blood tests - ecancer
Test Shows if Smoldering Myeloma Will Become Multiple Myeloma | Patient Power
Adriana PERILLA-GLEN | Senior Research Project Manager | Master of Business Administration | Dana-Farber Cancer Institute, Boston | DFCI | Department of Medical Oncology
Santé: une subvention de la Fondation de l'ARC pour la recherche sur le cancer | Grand Lille TV
Loop | Mark Bustoros
Daniel Auclair on Twitter: "Wonderfully enlightening discussion @COMyCongress with @NoopurRajeMD @End_myeloma @SagarLonialMD @Mohty_EBMT and Salomon Manier on bispecifics and #CART in #myeloma #COMy20 #mmsm… https://t.co/EvB6kijw2q"
Salomon Manier | Videos & Research | VJHemOnc
Myeloma Crowd Radio: Irene Ghobrial, MD & Salomon Manier, MD, PhD, Dana Farber 09/27 by Myeloma Crowd Radio | Health
Irene Ghobrial on Twitter: "Salomon manier presenting on myc dependency in myeloma #ash19 #mmsm… "
Adriana Perilla Glen on Twitter: "Salomon Manier presenting his work in multiple myeloma using WES and Targeted Deep Seq of cfDNA @DanaFarber @IreneGhobrial Lab #ASH16… https://t.co/pCQeVxOzjU"
Irene Ghobrial, MD - Posts | Facebook
Dana-Farber Cancer Institute - Lab Team - Ghobrial Lab - Cell Metastasis or Cell Dissemination in Hematological Malignancies
PDF) Deregulation and Targeting of TP53 Pathway in Multiple Myeloma
Auteur - Dr Salomon MANIER
Dana-Farber Cancer Institute - Lab Team - Ghobrial Lab - Cell Metastasis or Cell Dissemination in Hematological Malignancies
Équipe : Facteurs de Persistance des cellules leucémiques - Canther
Sequencing multiple myeloma using blood tests - ecancer
Amgen Education - Post Event
Dana-Farber Cancer Institute - Lab Team - Ghobrial Lab - Cell Metastasis or Cell Dissemination in Hematological Malignancies
L'ARC soutient les recherches menées à l'IRCL - IRCL